Se ha denunciado esta presentación.
Se está descargando tu SlideShare. ×

End TB Save Lives.pptx

Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Cargando en…3
×

Eche un vistazo a continuación

1 de 24 Anuncio
Anuncio

Más Contenido Relacionado

Más reciente (20)

Anuncio

End TB Save Lives.pptx

  1. 1. END TB : SAVE LIVES DR. NILIMA SONAWANE PhD(N), MPhil, PGDDM, PGDEM, MBA ( Health care Management) PROFESSOR CUM PRINCIPAL INSTITUTE OF NURSING EDUCATION, MUMBAI
  2. 2. End TB : Save Lives
  3. 3. GOLBAL TB BURDEN • TB is one of the top 10 cause of death worldwide. It is also the leading killer of people with HIV and a major cause of deaths related to antimicrobial resistance. • Estimated 10 million new TB cases diagnosed worldwide, of which 5.8 million are men, 3.2 million women and 1 million children. • People living with HIV accounted for 9% of the total.
  4. 4. • Eight countries accounts 66% of the new cases: India, China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa. • +1.6 million people died from TB, including 0.3 million among people with HIV. GLOBAL TB BURDEN
  5. 5. TB BURDEN IN INDIA • TB continues to be India's severest health crisis. • Mortality due to TB is the third leading cause of years of life lost (YLLs). • TB kills an estimated 480,000 Indians every year and more than 1,400 every day. • Approximately 5% of the TB cases have co-morbidity with HIV. • India accounts for 1,47,000 estimated MDR-RR cases which is 24% of the Global cases.
  6. 6. WHAT IS TUBERCULOSIS Tuberculosis (TB) is a potentially serious infectious disease that mainly affects the lungs. The bacteria that cause tuberculosis are spread from person to person through tiny droplets released into the air via coughs and sneezes. Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis.
  7. 7. SIGNS AND SYMPTOMS OF ACTIVE TB •Coughing for three or more weeks •Chest pain, or pain with breathing or coughing •Coughing up blood or mucus •Unintentional weight loss •Fatigue •Fever •Night sweats •Chills •Loss of appetite
  8. 8. INVESTIGATION IN TB • History • Clinical Examination • Mantoux Test or tuberculin test • X Ray Chest /MRI • Sputum test
  9. 9. MOST COMMON TB DRUGS DOTS Directly Observed Treatment Short Course The most common medications used to treat tuberculosis include: •Isoniazid •Rifampin •Ethambutol •Pyrazinamide
  10. 10. END TB • The National TB Programme (NTP) was launched by the Government of India in 1962 • In 1978, BCG (Bacille Calmette-Guerin) vaccination was shifted under the Expanded Programme on Immunisation. • The Government of India revitalized NTP as Revised National TB Control Programme (RNTCP) in the same year. • DOTS was officially launched as the RNTCP strategy in 1997 and by the end of 2005 the entire country was covered under the programme.
  11. 11. • TB was the leading cause of illness and death among persons living with HIV/AIDS and large number of multidrug resistant TB (MDR-TB) cases were reported every year. • Long term vision of a “TB free India” • National Strategic Plan (NSP) for TB 2012-2017 the goal of ‘universal access to quality TB diagnosis and treatment for all TB patients in the community’. END TB
  12. 12. ‘National strategic plan for tuberculosis elimination 2017-2025’- RNTCP has released a ‘National strategic plan for tuberculosis 2017-2025’ (NSP) for the control and elimination of TB in India by 2025. According to the NSP TB elimination have been integrated into the four strategic pillars of “Detect – Treat – Prevent – Build” (DTPB).
  13. 13. Detect  Notification of TB cases  NIKSHAY  Public Private Partnership
  14. 14. Treat  Fixed dose combinations (FDCs)  For new TB cases Intensive phase (IP) consists of 8 weeks of Isoniazid (INH), Rifampicin, Pyrazinamide Ethambutol Continuation phase(CP) three drug FDCs- Rifampicin, Isoniazid, and Ethambutol (HRE) are continued for 16 weeks.
  15. 15.  For previously treated cases of TB Intensive Phase is of 12 weeks, where injection streptomycin is given for 8 weeks along with four drugs (INH, Rifampicin, Pyrazinamide and Ethambutol) and after 8 weeks the four drugs (INH, Rifampicin, Pyrazinamide and Ethambutol) in daily doses as per weight bands are continued for another four weeks. Continuation phase Rifampicin, INH, and Ethambutol are continued for another 20 weeks as daily doses. Treat
  16. 16. On the basis of the drug susceptibility profile, a standard first-line treatment regimen (2HRZE/4HR) can be repeated if no resistance is documented; and if rifampicin resistance is present, shorter regimen for MDR-TB (multi drug resistant TB) regimen should be prescribed according to WHO’s recent drug resistant TB treatment guidelines. RNTCP has introduced Bedaquiline CAP for MDR-TB under conditional access programme in 2016 across six sites, with a country wide scale up plan in 2017-2020.
  17. 17. Prevent With the objective to prevent emergence of TB in susceptible population various measures are indicated as:  Scale up air-borne infection control measures at Health Facilities  Treatment for latent TB infection  Compliance to TB Treatment  Prevent MDR-TB  Address social determinants of TB through inter-sectoral approach.
  18. 18.  Social Awareness  Air borne infection control measures  Contact tracing  BCG vaccination  Addressing social determinants of TB Prevent
  19. 19. Build Health system strengthening for TB control under the National Strategic Plan 2017-2025 is recommended in the form of building and strengthening enabling policies, empowering institutions and human resources with enhanced capacities.
  20. 20. Conclusion • The global public health and TB community is shifting its focus from control of the TB epidemic towards elimination. • India has committed to END TB and is at a critical stage with the national momentum expected to accelerate after the increased political commitment and heightened community awareness about public health and hygiene and the threat of communicable disease following the COVID-19 pandemic.
  21. 21. References • tbcindia.gov.in/index1&lid=3578 • https://www.nhp.gov.in/revised-national-tuberculosis- control-programme_pg • https://www.who.int/southeastasia/news/detail/24-03- 2022-world-tuberculosis-day-invest-to-end-tb.-save-lives • https://communitysupport.nikshay.in/ • https://reports.nikshay.in/Reports/TBNotification# • https://tbcindia.gov.in/index1.php?lang=1&level=2&subli nkid=5507&lid=3528
  22. 22. END TB , SAVE LIVES

×